COURSE CREDITS & HOURS
1.5 AMA PRA Category 1 Credits™15 ACPE Credits
15.0 Contact Hours
COURSE FEES
In Person Conference Registration:3 Day Fee: $675
2 Day Fee: $575
1 Day Fee: $475
Conference Surcharge if not staying on site at hotel: $50.00 (see Conference Policies)
Live Stream Webcast Registration:
3 Day Fee: $550
2 Day Fee: $450
1 Day Fee: $350
Live Stream Webcast registration includes live conference streaming, access to online course materials and documentation of continuing education credit*.
Spouses, family and friends are welcome and do not need to register unless they attend the educational sessions. Special seminar fees are available for non-professional accompanying persons who wish to attend one or more session (no special receipt, certification or credit issued).
TARGET AUDIENCE
PROGRAM PURPOSE
Hot Topics in Infectious Diseases: New Antimicrobials, Penicillin Allergy De-labeling, Shorter Durations of Therapy, and more IV to PO conversion in complicated infections
5 hours | Wednesday, 6/9/2021
Check-in and Breakfast: 7:30AM PST
Educational Session: 8:00AM 1:30PM PST
At the conclusion of this program, the participant will be able to:
- Review various newer antimicrobials that have been FDA-approved.
- Evaluate these agents critically for use in clinical practice.
- Discuss penicillin allergies including long-term implications.
- Describe process and recent data supporting intervention strategies to de-label patients.
- Describe disease states for which shorter durations of therapy data are growing.
Hot Topics in Ambulatory Care: New Asthma Guidelines, Migraine Prophylaxis including CGRP antagonists, and COVID-19 for the Primary Care Provider
5 hours | Thursday, 6/10/2021
Check-in and Breakfast: 7:30AM PST
Educational Session: 8:00AM 1:30PM PST
At the conclusion of this program, the participant will be able to:
- Describe new recommendations to recently published asthma guidelines.
- Discuss changes in asthma medication recommendations.
- Discuss current role of traditional agents for migraine prophylaxis.
- Describe role of newer CGRP antagonists within migraine prophylaxis.
- Review acute effects of COVID-19 on the primary care provider.
- Provide guidance in managing long-term complications of COVID-19 for the primary care provider.
Preventive Cardiovascular Pharmacotherapy Update: A Case-Based Approach
5 hours | Friday, 6/11/2021
Check-in and Breakfast: 7:30AM PST
Educational Session: 8:00AM 1:30PM PST
At the conclusion of this program, the participant will be able to:
- Review medications and lifestyle modifications that are recommended for the treatment and prevention of cardiovascular disease.
- Explain recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with hypertension, hypercholesterolemia, heart failure with reduced ejection fraction, peripheral arterial disease and atrial fibrillation.
- Formulate a care plan for patients with resistant hypertension based on the 2018 American Heart Association scientific statement.
- Describe the evidence supporting bedtime dosing of antihypertensive medications.
- Apply the treatment approaches recommended in the 2018 ACC-AHA cholesterol guideline to patients with hypercholesterolemia.
- Define the evidence and role in therapy of nonstatin medications in the treatment of hypercholesterolemia.
- Examine results from cardiovascular outcome trials evaluating the use of angiotensinneprilysin inhibition in heart failure with reduce ejection fraction.
- Compare and contrast the evidence and guideline recommendations supporting the use of antiplatelet therapy for primary and secondary prevention patients.
- Examine the evidence-based CV risk reduction benefits of medications used to treat type 2 diabetes.
- Create treatment plans that reduce the risk of cardiovascular disease.
IMPORTANT INFORMATION
Faculty
Christopher M. Bland, Pharm.D., FCCP, FIDSA, BCPS
Clinical Associate Professor, University of Georgia College of Pharmacy Clinical and Administrative Pharmacy; Clinical Pharmacy Specialist, St. Joseph's/Candler Health System, Savannah, Georgia. Dr. Bland has an affiliation with Merck Pharmaceuticals, Biomerieux Diagnostics, and La Jolla Pharmaceuticals.
Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP
Professor and Vice Chair, Department of Clinical Pharmacy; Professor, Department of Family Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO. Dr. Saseen has NO financial arrangements with any corporate organization that might have an interest in the subject being presented.
Accreditation
University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for pharmacists. |
ITINERARY
DATE | PORT OF CALL | ARRIVE | DEPART |
---|---|---|---|
Wed Jun 09 | Las Vegas, Nevada |
- | - |
Thu Jun 10 | - | - |
PORTS OF CALL
Las Vegas, Nevada -
-
Westgate Las Vegas Resort & Casino
Register your interest and receive a full quote at 800-422-0711 (US/Can) or direct/int'l tel: +1-727-526-1571 or by registering online.
Prices below are for the full cruise including meals and evening entertainment
Cruise pricing is presented per person, based double occupancy of the stateroom, per standard industry practice. Pricing presented above is listed accordingly to allow easy comparison for the stateroom categories displayed. Our agents always provide 'total cost' pricing disclosing all particulars before you make any commitment.
3rd/4th in Stateroom - Please call to secure the best possible pricing
Course Fee Cancellation Policy: 30+ days before sailing date - 75% Refund ; 7-29 days before sailing date - 50% Refund; Less than 7 days before sailing date - No Refund